GOSS Gossamer Corp: Earnings per share for the last twelve months
Gossamer Bio, Inc. (GOSS) aims to set new standards for pulmonary hypertension therapy within the immunology sector. The current trailing twelve-month EPS confirms this trajectory, with the metric standing at -45.77. Drug development relies on AI algorithms and synthesis automation, while experts oversee the clinical stage. Favorable options for lead researchers ensure team stability.
Analytical breakdowns and data insights for company Gossamer Bio Inc (GOSS)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
- earnings and valuation multiples indicators:
GOSS - Net Financial Result|Projected Future Earnings Gossamer Bio, Inc.|GOSS - P/E Multiple|Future Price to Earnings Gossamer Bio|GOSS - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Gossamer Bio, Inc.|GOSS - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Gossamer Bio|GOSS - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months gossamerbio.com|GOSS - Earnings per share increase in current year|Earnings growth forecast for next year Gossamer Bio, Inc.
Comprehensive company analysis:GOSS - Gossamer Bio, Inc.
Gossamer Bio, Inc. (GOSS) is currently in a stage of intensive clinical trials, where operating expenses temporarily exceed revenues. By analyzing the company's specific annual revenue metric, an investor assesses the rolling net income divided by the number of shares, which allows for a comparison of the actual equity return against the cost of capital. The current negative trend reflects investments in a pulmonary hypertension drug that are already priced into the market value.
Main competitors
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|Aurinia Pharma - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year BioCryst Corp (BCRX)|Vera Therapeutics, Inc. (VERA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months dianthustx.com (DNTH)|Earnings per share for the last twelve months Pharvaris|AbCellera Biologics Inc (ABCL) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Tourmaline Corp (TRML)|Net earnings per share for the last four quarters Precigen Corp|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|Net earnings per share (EPS TTM) nektar.com NKTR|UPB - Earnings per share for the last twelve months|Zenas Bio (ZBIO) - Net earnings per share for the last 12 months|IMNM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months KalVista Corp (KALV)|Earnings per share for the last twelve months Septerna Inc|PVLA: Earnings per share for the trailing year|Net earnings per share for the last 12 months SVRA (Savara)|RIGL (Rigel Pharma) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ANAB (AnaptysBio Corp)|Astria Corp - Earnings per share for the last twelve months|enGene Holdings Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters RAPT Therapeutics Inc. RAPT|aerovatetx.com (JBIO) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Aclaris Therapeutics Inc. (ACRS)|Net earnings per share for the last 12 months KYTX|TLSA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CABA|Net earnings per share for the last four quarters ventyxbio.com|Earnings per share for the last twelve months Theratechnologies THTX|AVTX: Earnings per share for the last 12 months|Eledon - Net earnings per share (EPS TTM)|Agenus, Inc (AGEN) - Net earnings per share for the last 12 months|CLYM (Climb Bio Inc) - Net earnings per share for the last 12 months|ZURA - Net earnings per share for the last four quarters|ATYR (aTyr Pharma) - Net earnings per share (EPS TTM)|ADAG - Net earnings per share for the trailing year|Earnings per share for the last twelve months ImageneBio Inc (IMA)|STTK - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Equillium EQ|Net earnings per share for the last four quarters Connect Biopharma Holdings (CNTB)|IMUX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Atara Biotherapeutics ATRA|inflarx.de (IFRX) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months XFOR (X4 Pharmaceuticals, Inc)|ACET (Adicet Bio Inc.) - Net earnings per share (EPS TTM)|CELU: Earnings per share for the trailing year|Net earnings per share (EPS TTM) INMB|Net earnings per share (EPS TTM) Barinthus Biotherapeutics PLC (BRNS)|Earnings per share for the last twelve months Kezar Life Sciences, Inc KZR|Earnings per share for the trailing year SABS|AKTX - Earnings per share for the last twelve months|Enlivex Therapeutics (ENLV) - Net earnings per share for the last 12 months|QTTB: Net earnings per share (EPS TTM)|GeoVax Labs (GOVX) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months EDSA|IBIO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CARM|Net earnings per share for the last four quarters xtlbio.com|Earnings per share for the last twelve months Bolt Biotherapeutics, Inc. BOLT|HCWB - Net earnings per share for the last 12 months|APVO - Earnings per share for the last twelve months|AIM ImmunoTech, Inc. (AIM) - Net earnings per share for the last 12 months|ADTX (aditxt.com) - Net earnings per share for the last 12 months|gribio.com (GRI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months XORTX Therapeutics|Earnings per share for the last 12 months HIND (Vyome Holdings Inc.)|Net earnings per share (EPS TTM) REVB|INDP - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) SCNI (Scinai Immunotherapeutics)|Net earnings per share for the trailing year CalciMedica Inc|AFMD - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Allakos Inc.|hookipapharma.com (HOOK) - Earnings per share for the last twelve months|IGMS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months iTeos Therapeutics|oceanbiomedical.com (OCEA) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) TCBP|Net earnings per share (EPS TTM) Third Harmonic Bio Inc. (THRD)
